FEELING BLUE: A CASE OF RASBURICASE-INDUCED METHEMOGLOBINEMIA
نویسندگان
چکیده
منابع مشابه
Dapsone-induced methemoglobinemia: case of the blue lady.
Methemoglobinemia is a life-threatening condition that can be difficult to diagnose. While methemoglobinemia can be congenital and should be considered in cyanotic infants,1 it is more often an adverse medication effect, most commonly related to dapsone use.2 As up to 1 in 9 emergency department visits in Canada might be owing to adverse medication effects, physicians and other health care prov...
متن کاملRasburicase‐induced methemoglobinemia: case report, literature review, and proposed treatment algorithm
Rasburicase for the treatment of tumor lysis syndrome has been associated with hemolytic anemia and methemoglobinemia, usually in patients with G6PD deficiency. Risks and benefits should be considered prior to use of rasburicase in at-risk patients. Methylene blue will worsen the hemolytic anemia in G6PD deficiency and should be avoided.
متن کاملA Case of Severe Amyl Nitrite Induced Methemoglobinemia Managed with Methylene Blue
Brian Faley1,2,* and Howard Chase3 1Clinical Assistant Professor, Ernest Mario School of Pharmacy of Rutgers University, 160 Frelinghuysen Rd, Piscataway, NJ 08854, USA 2Clinical Pharmacist, Emergency Medicine, Hackensack University Medical Center, 30 Prospect Ave., Hackensack, NJ 07601, USA 3Department of Emergency Trauma, Hackensack University Medical Center, 30 Prospect Ave., Hackensack, NJ ...
متن کاملRasburicase-Induced Methemoglobinemia in a Patient with Aggressive Non-Hodgkin’s Lymphoma
BACKGROUND Rasburicase is a recombinant urate oxidase enzyme that converts uric acid to allantoin (an inactive and soluble metabolite that is readily excreted in urine). It is used for the management of tumor lysis syndrome (TLS) in cancer patients receiving chemotherapy. Although rasburicase is a generally safe and effective treatment, it can be associated with the rare and potentially severe ...
متن کاملExchange transfusion as treatment for rasburicase induced methemoglobinemia in a glucose-6-phosphate dehydrogenase deficient patient.
To the Editor: A recent letter in this journal described methemoglobinemia and hemolysis due to rasburicase in a patient with glucose-6-phosphate dehydrogenase (G6PD) deficiency [1]. We would like to report on the management of a patient with rasburicase induced methemoglobinemia and G6PD deficiency. DS is a 12-year-old Laotian male who presented with a white blood cell count of 533,900/mm (89%...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Chest
سال: 2019
ISSN: 0012-3692
DOI: 10.1016/j.chest.2019.08.1926